In the News: Goldman Sachs-CSRC Settlement; First Sci-Tech Board Funds Approved; and Drug Administration Law Under Review
| BY
Marilyn RomeroThe CSRC has agreed its first administrative settlement with Goldman Sachs and Gao Hua Securities; seven themed funds were approved for Shanghai's new Sci-Tech Board; and the National People's Congress is reviewing measures to tighten up the production and sale of drugs.
CSRC agrees first administrative settlement with Goldman Sachs
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]